Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

MedImmune To Close Two California Sites

by Rick Mullin
July 23, 2012 | A version of this story appeared in Volume 90, Issue 30

MedImmune, the biologics arm of drugmaker AstraZeneca, will close research facilities in Mountain View and Santa Clara, Calif., eliminating approximately 200 jobs. It will relocate another 100 jobs to other MedImmune facilities, including one in Hayward, Calif. The closure is part of a two-year consolidation and cost-cutting program announced by AstraZeneca in February. It is expected to be completed in 2014.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.